Computer-aided Systems May Speed up New Anticancer Drug Development
Researchers analyzed different subareas of CADD process with a focus on anticancer drugs.
AI Technology & Industry Review
Researchers analyzed different subareas of CADD process with a focus on anticancer drugs.
A new study leverages an established AI-based drug discovery pipeline to produce molecular structures as part of the widening fight against the 2019-nCoV outbreak.
The crucial step now is to develop matching vaccines and drugs to uproot its existence, and China’s big tech companies have stepped up to help.
Insilico Medicine, a drug discovery startup located in Johns Hopkins University, has introduced MOSES (Molecular Sets), a platform which can be used to compare model accuracy in molecular generation. MOSES provides a standardized benchmarking dataset, a set of open-sourced models with unified implementation, and evaluation metrics.
In December 2017 Chinese pharma tech startup AccutarBio raised US$15 million from IDG Capital, YITU Tech, and ZhenFund.
The US FDA defines five steps for the development of a new drug: discovery and development, preclinical research, clinical research, FDA review, and FDA post-market safety monitoring.